Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May;102(5):854–864. doi: 10.3324/haematol.2016.153528

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© Ferrata Storti Foundation

Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

PMC Copyright notice

Figure 4. — Time to in vivo engraftment and mouse survival correlate with molecular risk group stratification of the transplanted acute myeloid leukemia. (A) Favorable-risk AML showed longer time to engraftment when compared to intermediate- or adverse-risk AML. (B) Kaplan-Meier survival analysis of 99 mice transplanted with human AML indicates that mouse survival depends on the AML molecular risk group. Note that animals transplanted with favorable-risk AML cases showed the longest survival. (black: favorable, n=4; blue: intermediate (I+II), n=8; red: adverse risk AML, n=3). See Table 1 for transplanted/engrafted mouse numbers per individual AML case. A log-rank (Mantel-Cox) test was applied to calculate statistical significance.